These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 23396438)

  • 1. The small molecule Retro-1 enhances the pharmacological actions of antisense and splice switching oligonucleotides.
    Ming X; Carver K; Fisher M; Noel R; Cintrat JC; Gillet D; Barbier J; Cao C; Bauman J; Juliano RL
    Nucleic Acids Res; 2013 Apr; 41(6):3673-87. PubMed ID: 23396438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Family of Small Molecules that Enhance the Intracellular Delivery and Pharmacological Effectiveness of Antisense and Splice Switching Oligonucleotides.
    Wang L; Ariyarathna Y; Ming X; Yang B; James LI; Kreda SM; Porter M; Janzen W; Juliano RL
    ACS Chem Biol; 2017 Aug; 12(8):1999-2007. PubMed ID: 28703575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput screening identifies small molecules that enhance the pharmacological effects of oligonucleotides.
    Yang B; Ming X; Cao C; Laing B; Yuan A; Porter MA; Hull-Ryde EA; Maddry J; Suto M; Janzen WP; Juliano RL
    Nucleic Acids Res; 2015 Feb; 43(4):1987-96. PubMed ID: 25662226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retro-1-Oligonucleotide Conjugates. Synthesis and Biological Evaluation.
    Agramunt J; Pedroso E; Kreda SM; Juliano RL; Grandas A
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30736307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retro-1 Analogues Differentially Affect Oligonucleotide Delivery and Toxin Trafficking.
    Yang B; Ming X; Abdelkafi H; Pons V; Michau A; Gillet D; Cintrat JC; Barbier J; Juliano R
    ChemMedChem; 2016 Nov; 11(22):2506-2510. PubMed ID: 27778487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of a splice-switching oligonucleotide by cationic polyplexes of RGD-oligonucleotide conjugate.
    Ming X; Feng L
    Mol Pharm; 2012 May; 9(5):1502-10. PubMed ID: 22497548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugation with receptor-targeted histidine-rich peptides enhances the pharmacological effectiveness of antisense oligonucleotides.
    Nakagawa O; Ming X; Carver K; Juliano R
    Bioconjug Chem; 2014 Jan; 25(1):165-70. PubMed ID: 24354269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular uptake and intracellular trafficking of oligonucleotides: implications for oligonucleotide pharmacology.
    Juliano RL; Ming X; Carver K; Laing B
    Nucleic Acid Ther; 2014 Apr; 24(2):101-13. PubMed ID: 24383421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense Oligonucleotides for Splice Modulation: Assessing Splice Switching Efficacy.
    Rocha CSJ
    Methods Mol Biol; 2019; 2036():73-90. PubMed ID: 31410791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of pre-mRNA splicing by antisense oligonucleotides.
    Kole R
    Acta Biochim Pol; 1997; 44(2):231-7. PubMed ID: 9360712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Don't.
    Juliano RL
    Nucleic Acid Ther; 2018 Jun; 28(3):166-177. PubMed ID: 29708838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical Manipulation of the Endosome Trafficking Machinery: Implications for Oligonucleotide Delivery.
    Juliano RL
    Biomedicines; 2021 May; 9(5):. PubMed ID: 34063104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of MKNK2 alternative splicing by splice-switching oligonucleotides as a novel approach for glioblastoma treatment.
    Mogilevsky M; Shimshon O; Kumar S; Mogilevsky A; Keshet E; Yavin E; Heyd F; Karni R
    Nucleic Acids Res; 2018 Nov; 46(21):11396-11404. PubMed ID: 30329087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2'-O-Lysylaminohexyl oligonucleotides: modifications for antisense and siRNA.
    Winkler J; Gilbert M; Kocourková A; Stessl M; Noe CR
    ChemMedChem; 2008 Jan; 3(1):102-10. PubMed ID: 17979170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides.
    Aung-Htut MT; McIntosh CS; Ham KA; Pitout IL; Flynn LL; Greer K; Fletcher S; Wilton SD
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reprogramming alternative pre-messenger RNA splicing through the use of protein-binding antisense oligonucleotides.
    Villemaire J; Dion I; Elela SA; Chabot B
    J Biol Chem; 2003 Dec; 278(50):50031-9. PubMed ID: 14522969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined treatment with the histone deacetylase inhibitor LBH589 and a splice-switch antisense oligonucleotide enhances SMN2 splicing and SMN expression in Spinal Muscular Atrophy cells.
    Pagliarini V; Guerra M; Di Rosa V; Compagnucci C; Sette C
    J Neurochem; 2020 Apr; 153(2):264-275. PubMed ID: 31811660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions.
    Astriab-Fisher A; Sergueev D; Fisher M; Shaw BR; Juliano RL
    Pharm Res; 2002 Jun; 19(6):744-54. PubMed ID: 12134943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligonucleotide analogs as antiviral agents.
    Fabani MM; Turner JJ; Gait MJ
    Curr Opin Mol Ther; 2006 Apr; 8(2):108-14. PubMed ID: 16610762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis.
    Vickers TA; Koo S; Bennett CF; Crooke ST; Dean NM; Baker BF
    J Biol Chem; 2003 Feb; 278(9):7108-18. PubMed ID: 12500975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.